2026 Expected to Be a Record Year AVACEN was founded by two military families. We have always helped our military community whenever possible. Our dream has continuously been to have an AVACEN device available to all Veterans in need.” — Danielle Forsgren, President CARLSBAD, CA, UNITED STATES, December 31, 2025 / EINPresswire.com / -- AVACEN Medical ® (AVACEN), a leading developer, manufacturer, and the #1 global distributor of noninvasive, FDA-Cleared Class II, palm-based, thermo-therapy medic

RIYADH, SAUDI ARABIA, December 31, 2025 / EINPresswire.com / -- King Faisal Specialist Hospital & Research Centre continues to play a leading regional role in pediatric stem cell transplantation through a highly specialized program serving children with malignant and non-malignant diseases, inherited blood disorders, immunodeficiencies, and metabolic conditions. The Pediatric Stem Cell Transplant Program performs approximately 130 transplants annually for patients from birth to under 14 years of

DUBLIN--(BUSINESS WIRE)--The "NovoCure Ltd (NVCR) - Product Pipeline Analysis, 2025 Update" company profile has been added to ResearchAndMarkets.com's offering. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. NovoCure Ltd (NovoCure) is an oncology company with a focus on the development and commercialization of novel delivery systems for t

Avinasi Labs Enables a New Funding & Revenue Model for Clinical Stage Assets via DeLong Protocol SAN FRANCISCO, CA, UNITED STATES, December 31, 2025 / EINPresswire.com / -- Avinasi Labs , an AI-native longevity infrastructure company building the world’s first liquid foundation model for aging science, today announced a $15 million clinical-stage assetization Memorandum of Understanding (“MoU”) with Fermion , a cutting-edge AI-driven biotechnology company advancing small-molecule drug discovery.

IDAHO FALLS, Idaho, Dec. 31, 2025 /PRNewswire/ -- International Isotopes Inc. ("INIS" or the "Company") (OTCQB:INIS) today announced that it has filed a Certificate of Amendment in the State of Texas to change our legal name to Radnostix, Inc. Effective immediately, we will officially begin to rebrand all of our operations under the Radnostix name. INIS was started in 1995 as a company focused on irradiation and manufacturing of industrial radioisotope products. Over the years, our focus has evo

Board brings together internationally recognized leaders in immunology, oncology, and translational science to guide next-gen immune-engineering platforms. FORT LAUDERDALE, FL, UNITED STATES, December 31, 2025 / EINPresswire.com / -- Lurex Bio Inc., a biotechnology company advancing next-generation immune-engineering platforms, today announced the formation of its Scientific Advisory be Board (SAB), composed of internationally recognized leaders in immunology, oncology, translational science, an

New Delhi: While patients in India familiarize themselves with the once-weekly GLP-1 injectable routine, Lupin is betting on a biweekly brand to leapfrog its rivals in country’s booming type-2 diabetes and weight-loss drug markets. Without disclosing the deal financial terms, earlier this week the Mumbai-based drugmaker announced an exclusive distribution agreement with China’s Gan & Lee Pharmaceuticals , in-licensing India rights of an investigational fortnightly GLP-1 receptor agonist , ‘ Bofa

Vancouver, Canada, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel neuroplastogen-derived therapeutics to solve major under-treated health problems, announced that it has received a notification letter from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”), informing the Company that it has regained compliance with t

Flu cases have begun to steady but hospital cases still surpassed 3,000 in the week before Christmas, a slight fall on the week before, according to new figures published today. Thanks in part to NHS staff ramping up vaccination efforts with half a million more people protected against flu compared to the same period last year, flu cases have not risen further. Hospitals still remain extremely busy with around 95 per cent of adult beds filled and 94,118 patients in hospital each day. Other winte

JEDDAH, SAUDI ARABIA, December 31, 2025 / EINPresswire.com / -- King Faisal Specialist Hospital and Research Centre (KFSHRC) in Jeddah has manufactured and introduced a post-transplant booster dose for bone marrow transplant patients, an advanced cellular immunotherapy designed to support transplant success and reduce the risk of relapse. The milestone is a first for the Western Region’s healthcare sector, giving patients quicker, safer access to specialized follow-up care while sparing them the